Legend Biotech Corp Description Of Expected Volatility Share Options Granted
Legend Biotech Corp (LEGN) reported Description Of Expected Volatility Share Options Granted of 59.00% for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-10.
Financial Statements › Notes
ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted · last filed 2026-03-10
| Period end | Description Of Expected Volatility Share Options Granted 12 month |
|---|---|
| 2025-12-31 | 59.00% 20-F · filed 2026-03-10 |
| 2024-12-31 | 76.90% 20-F · filed 2026-03-10 |
| 2023-12-31 | 66.10% 20-F · filed 2026-03-10 |